• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移民率上升地区镰状细胞病患儿的住院情况。

Hospitalization of children with sickle cell disease in a region with increasing immigration rates.

作者信息

Colombatti Raffaella, Dalla Pozza Laura Visonà, Mazzucato Monica, Sainati Laura, Pierobon Marta, Facchin Paola

出版信息

Haematologica. 2008 Mar;93(3):463-4. doi: 10.3324/haematol.11766.

DOI:10.3324/haematol.11766
PMID:18310539
Abstract

Sickle cell disease (SCD) has become a paradigm of immigration hematology in Europe. Accurate up-to date information is needed to determine SCD prevalence, define real burden of disease and develop appropriate clinical networks of care, especially in regions lacking screening programs. We used two independent sources of data (Regional Register of Rare Disorders and Regional Register of Hospital Discharge Records) to determine extent of SCD and pattern of hospitalization of pediatric patients in the Veneto Region of NorthEast Italy. A steady increase of case notifications and hospitalizations has been observed in the past five years. Ninety-five percent of patients are immigrants with HbS/HbS SCD. Specialized regional registers can be used to define disease extent and guide targeted interventions in regions still lacking comprehensive care screening programs.

摘要

镰状细胞病(SCD)已成为欧洲移民血液学的一个范例。需要准确的最新信息来确定SCD的患病率,明确疾病的实际负担,并建立适当的临床护理网络,尤其是在缺乏筛查项目的地区。我们使用了两个独立的数据来源(罕见疾病区域登记册和医院出院记录区域登记册)来确定意大利东北部威尼托地区儿科患者的SCD范围和住院模式。在过去五年中,病例报告和住院人数稳步增加。95%的患者是携带HbS/HbS SCD的移民。专门的区域登记册可用于确定疾病范围,并指导在仍缺乏全面护理筛查项目的地区进行有针对性的干预。

相似文献

1
Hospitalization of children with sickle cell disease in a region with increasing immigration rates.移民率上升地区镰状细胞病患儿的住院情况。
Haematologica. 2008 Mar;93(3):463-4. doi: 10.3324/haematol.11766.
2
One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.荷兰三分之一的新儿科镰状细胞病患者是移民,他们无法从新生儿筛查中受益。
Arch Dis Child. 2010 Oct;95(10):822-5. doi: 10.1136/adc.2009.165290. Epub 2010 Jun 24.
3
Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease.距离综合性镰状细胞中心的远近对镰状细胞病患儿医疗服务利用情况的影响。
Pediatr Blood Cancer. 2008 Jan;50(1):66-71. doi: 10.1002/pbc.21066.
4
Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.患有镰状细胞病和人类免疫缺陷病毒-1感染的儿童:美国住院护理服务的使用情况
Pediatr Infect Dis J. 2007 May;26(5):406-10. doi: 10.1097/01.inf.0000259953.79654.d0.
5
The Changing Epidemiology of Pediatric Hemoglobinopathy Patients in Northern Alberta, Canada.加拿大艾伯塔省北部小儿血红蛋白病患者的流行病学变化
J Pediatr Hematol Oncol. 2015 Nov;37(8):595-9. doi: 10.1097/MPH.0000000000000442.
6
Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.科威特镰状细胞病患儿住院情况十年回顾。
Med Princ Pract. 2008;17(5):404-8. doi: 10.1159/000141506. Epub 2008 Aug 6.
7
Trends in comorbid sickle cell disease among stroke patients.中风患者合并镰状细胞病的趋势。
J Neurol Sci. 2012 Feb 15;313(1-2):86-91. doi: 10.1016/j.jns.2011.09.023. Epub 2011 Oct 10.
8
Sickle cell disease: the Lebanese experience.镰状细胞病:黎巴嫩的经验
Int J Lab Hematol. 2007 Dec;29(6):399-408. doi: 10.1111/j.1751-553X.2007.00964.x.
9
Survey of sickle cell disease in Italy.意大利镰状细胞病调查。
Haematologica. 1998 Oct;83(10):875-81.
10
Asthma and acute chest in sickle-cell disease.镰状细胞病中的哮喘与急性胸痛
Pediatr Pulmonol. 2004 Sep;38(3):229-32. doi: 10.1002/ppul.20066.

引用本文的文献

1
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in Italy.十年的新生儿血红蛋白病筛查计划在弗留利-威尼斯朱利亚地区:意大利的首次区域经验。
Blood Transfus. 2024 Nov;22(6):529-536. doi: 10.2450/BloodTransfus.646. Epub 2023 Nov 30.
2
Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience.镰状细胞病:将患者参与融入国际会议可以改变患者经验的作用。
Orphanet J Rare Dis. 2023 Nov 1;18(1):341. doi: 10.1186/s13023-023-02951-8.
3
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
制定改善镰状细胞病结局的全球战略:柳叶刀血液学委员会。
Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11.
4
Real-world use of orphan medicinal products (OMPs) in rare disease (RD) patients: A population-based registry study.罕见病(RD)患者中孤儿药(OMPs)的真实世界使用情况:一项基于人群的注册研究。
Front Pharmacol. 2022 Sep 30;13:940010. doi: 10.3389/fphar.2022.940010. eCollection 2022.
5
Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening.西非几内亚比绍多民族人群中血红蛋白S等位基因和单倍型的分布:对公共卫生筛查的启示
Front Pediatr. 2022 Apr 7;10:826262. doi: 10.3389/fped.2022.826262. eCollection 2022.
6
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority.意大利镰状细胞病患儿的疾病负担和生活质量:是时候将其视为优先事项了。
Ital J Pediatr. 2021 Jul 29;47(1):163. doi: 10.1186/s13052-021-01109-1.
7
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective.一项促进小儿镰状细胞病经颅多普勒超声筛查实施的教育研究:欧洲多中心视角
J Clin Med. 2019 Dec 24;9(1):44. doi: 10.3390/jcm9010044.
8
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.当前镰状细胞病患者管理面临的挑战——意大利经验报告。
Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0.
9
The Epidemiology of Transition into Adulthood of Rare Diseases Patients: Results from a Population-Based Registry.罕见病患者成年过渡期的流行病学:基于人群登记的研究结果。
Int J Environ Res Public Health. 2018 Oct 10;15(10):2212. doi: 10.3390/ijerph15102212.
10
A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.作为罕见病健康指标来源的基于人群的登记系统:威尼托地区罕见病登记系统的十年经验
Orphanet J Rare Dis. 2014 Mar 19;9:37. doi: 10.1186/1750-1172-9-37.